| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 4. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | cholecalciferol (Stexerol-D3) |
| Formulation | 1,000 IU and 25,000 IU film-coated tablet |
| Reference number | 2523 |
| Indication | Prevention and treatment of vitamin D deficiency in adults, the elderly and adolescents; as an adjunct to specific therapy for osteoporosis in patients with vitamin D deficiency or at risk of vitamin D insufficiency |
| Company | ProStrakan Ltd |
| BNF chapter | Nutrition & blood |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 17/04/2014 |